Acta Biomaterialia
Scope & Guideline
Pioneering Research for a Healthier Tomorrow
Introduction
Aims and Scopes
- Biomaterials Development:
Research dedicated to the synthesis and characterization of novel biomaterials, including hydrogels, scaffolds, and nanocomposites, which are designed to mimic the properties of natural tissues. - Tissue Engineering Approaches:
Studies that integrate biomaterials with cellular components to create functional tissue constructs aimed at repairing or replacing damaged tissues or organs. - Nanotechnology in Medicine:
Exploration of nanoscale materials and their applications in drug delivery, imaging, and therapy, focusing on enhancing the efficacy and specificity of treatments. - Biocompatibility and Safety Assessments:
Research focused on evaluating the biocompatibility and safety of biomaterials in biological systems, including in vitro and in vivo studies to understand interactions with tissues. - Mechanobiology and Material Interactions:
Investigations into how mechanical properties of biomaterials influence cellular behavior, including differentiation, migration, and response to stimuli. - Immunomodulatory Biomaterials:
Development of materials that can modulate immune responses, particularly in the context of inflammation and tissue regeneration. - Smart and Responsive Systems:
Research on biomaterials that respond to environmental stimuli (pH, temperature, light) to enhance functionality and control drug release.
Trending and Emerging
- 3D Bioprinting and Tissue Engineering:
There is a significant rise in studies focusing on 3D bioprinting technologies for creating complex tissue structures, indicating a growing interest in personalized medicine and regenerative therapies. - Nanomaterials for Targeted Therapy:
The use of nanomaterials for targeted drug delivery and therapy is gaining momentum, particularly in cancer treatment, showcasing a trend towards precision medicine. - Bioactive and Responsive Hydrogels:
Research on smart hydrogels that respond to environmental stimuli for controlled drug delivery and tissue repair is increasingly prominent, reflecting advances in biomaterial functionality. - Extracellular Vesicles and Cell-Derived Therapeutics:
Emerging studies emphasize the role of extracellular vesicles in mediating therapeutic effects, particularly in regenerative medicine and cancer therapy, highlighting a shift towards using biological materials for treatment. - Mechanobiology and Tissue Interactions:
An increasing focus on the mechanical aspects of biomaterials and their influence on cellular responses indicates a deeper exploration of mechanobiology in tissue engineering. - Sustainable and Biodegradable Materials:
There is a growing trend towards the development of sustainable and biodegradable biomaterials, reflecting a shift in priorities towards environmental considerations in medical applications.
Declining or Waning
- Conventional Biomaterial Studies:
Traditional studies focused solely on the mechanical and chemical properties of biomaterials without considering biological interactions have become less prevalent, as the field shifts towards more integrated approaches that include biological responses. - Basic Material Characterizations:
There is a noticeable decline in publications that focus exclusively on basic characterization of materials (e.g., mechanical testing without biological context), as the emphasis has shifted towards applications and interactions in biological systems. - Single-Use or Non-Functional Materials:
Research on single-use biomaterials with limited functionality is waning as the field increasingly prioritizes multifunctional and adaptive materials that can respond to various physiological conditions. - Static In Vitro Models:
Studies using static in vitro models that do not replicate dynamic physiological conditions are less frequent, with a growing preference for more complex models that better mimic in vivo environments.
Similar Journals
Bioengineering & Translational Medicine
Driving Innovation from Lab to LifeBioengineering & Translational Medicine, published by WILEY, positions itself at the forefront of innovation in the fields of biomedical engineering, biotechnology, and pharmaceutical science. With an impressive impact factor reflected through its top-tier Q1 rankings in multiple categories, the journal serves as a critical platform for disseminating cutting-edge research and stimulating discourse among professionals and scholars since its establishment as an open-access journal in 2016. Key to its mission is facilitating the translation of bioengineering research into tangible medical applications, thereby enhancing healthcare outcomes. With its comprehensive scope, it attracts a diverse readership, including researchers, industry leaders, and students eager to engage with the latest developments in translational medicine. The journal operates under robust access options, ensuring that research is freely available for maximum reach and impact, fostering collaboration and innovation across disciplines worldwide.
Biomedical Materials
Innovative Insights for Enhanced Patient Care.Biomedical Materials, published by IOP Publishing Ltd, is a premier journal dedicated to the rapidly evolving field of biomedical engineering and materials science. With a robust impact factor showcasing its influence, this journal serves as a vital platform for disseminating pioneering research from 2006 to 2024. Covering an array of interdisciplinary topics—ranging from biomaterials to bioengineering and applied chemistry—the journal consistently ranks in the second quartile across multiple categories including Bioengineering (Q2), Biomaterials (Q2), and Biomedical Engineering (Q2) as of 2023. Researchers, professionals, and students alike benefit from its contributions, exploring innovative solutions at the intersection of biology and material science. Although not an Open Access journal, Biomedical Materials remains essential in advancing our understanding and facilitating discussions surrounding state-of-the-art materials that revolutionize medical applications and enhance patient care.
Materials
Connecting researchers to the latest breakthroughs in materials technology.Materials is an esteemed journal published by MDPI, dedicated to advancing the fields of Condensed Matter Physics and Materials Science. With its commitment to Open Access since its inception in 2008, the journal has made significant strides in disseminating high-quality research globally, allowing researchers, professionals, and students easy access to cutting-edge studies without financial barriers. Hailing from Switzerland, the journal has shown remarkable growth and prominence, currently ranked in the Q2 quartile in its categories according to the latest assessments, which highlights its impact within the community. As the journal converges its focus from 2008 to 2024, it aims to continually foster a robust exchange of knowledge on innovative materials and their applications, thereby supporting the evolving landscape of science and technology. With an E-ISSN of 1996-1944 and a user-friendly platform, Materials is poised to be a leading choice for scholars eager to contribute to and engage with pioneering research.
Frontiers in Bioengineering and Biotechnology
Pioneering Innovations for a Sustainable FutureFrontiers in Bioengineering and Biotechnology, published by FRONTIERS MEDIA SA in Switzerland, stands as a leading platform for innovative research and developments in the fields of bioengineering and biotechnology. Since its inception in 2013, this Open Access journal has garnered significant recognition, reflected in its impressive category rankings: Q1 in Biomedical Engineering and Q2 in Bioengineering, Biotechnology, and Histology for 2023. With a focus on fostering collaboration and knowledge sharing, it aims to provide researchers, professionals, and students with access to pioneering studies that push the boundaries of science and technology. The journal, which is indexed in prominent databases, boasts high visibility and impact, evidenced by its impressive rankings across various categories in Scopus. As it continues to converge from 2013 to 2024, Frontiers in Bioengineering and Biotechnology is dedicated to shaping the discourse in its field and promoting advancements that have the potential to transform healthcare and environmental sustainability.
MACROMOLECULAR BIOSCIENCE
Exploring the Nexus of Molecular Science and BiosystemsMACROMOLECULAR BIOSCIENCE, published by WILEY-V C H VERLAG GMBH, is a leading journal in the fields of bioengineering, biomaterials, biotechnology, materials chemistry, and polymers and plastics. With a convergence of scientific inquiry since its inception in 2001, the journal has established itself as a vital resource for researchers and professionals exploring the interface of molecular sciences and biosystems. It boasts impressive Scopus rankings, including Q1 status in multiple categories, reflecting its significant contribution to advancing knowledge and innovation in the polymer and biomaterials domains. While the journal does not currently offer open access options, its rigorous peer-review process ensures the publication of high-quality research that fuels academic discourse. Positioned in Weinheim, Germany, MACROMOLECULAR BIOSCIENCE aims to bridge theoretical understanding with practical applications, making it an essential reference for students, academics, and industry practitioners dedicated to the evolving landscape of macromolecular bioscience.
Biomaterials Research
Pioneering breakthroughs in materials for medicine.Biomaterials Research, published by the American Association for the Advancement of Science, is a prominent open access journal established in 2014, dedicated to advancing the field of biomaterials. Based in the United Kingdom, this journal has swiftly become an essential platform for researchers and practitioners, offering groundbreaking insights in biomaterials, biomedical engineering, ceramics and composites, and miscellaneous medical fields. With its impressive Q1 ranking across multiple relevant categories in 2023 and its strong Scopus rankings, including a remarkable 90th percentile in the medicine category, Biomaterials Research showcases high-quality, peer-reviewed research designed to address both practical and theoretical challenges in biomaterials science. As an open access journal, it promotes wider dissemination and accessibility of research findings, crucial for fostering innovation and collaboration within the scientific community. Researchers, professionals, and students alike are encouraged to contribute, read, and engage with the latest developments in this dynamic field.
Biofabrication
Transforming Ideas into Impactful Biofabrication Advances.Biofabrication, published by IOP Publishing Ltd, stands at the forefront of the interdisciplinary fields of biochemistry, bioengineering, biomaterials, biomedical engineering, biotechnology, and miscellaneous medicine. Since its inception in 2009, this prestigious journal has secured its position within the Q1 category across multiple disciplines as of 2023, reflecting its high impact and significant contribution to advancing research in these domains. With ranks such as #19 in biochemistry and #10 in biomaterials according to Scopus, it showcases groundbreaking studies and innovative methodologies that are crucial for the evolution of biofabrication technologies. Authored by leading researchers and professionals, the journal publishes articles that explore the synthesis, characterization, and application of biomaterials, providing valuable insights for both academic researchers and industry practitioners. The impact factor of the journal, combined with its rigorous peer-review process, guarantees high-quality content that pushes the boundaries of knowledge and technology. Researchers and students engaged in these dynamic fields will find Biofabrication an indispensable resource for staying abreast of critical developments and emerging trends.
Bioactive Materials
Empowering Researchers with Open Access to Transformative KnowledgeBioactive Materials, published by KEAI PUBLISHING LTD, stands as a leading Open Access journal in the fields of Biomaterials, Biomedical Engineering, and Biotechnology. Since its inception in 2016, this journal has rapidly ascended in prominence, currently holding a prestigious Q1 category ranking across multiple disciplines, reflecting its significant impact within the scientific community. With its E-ISSN 2452-199X, it spans a broad spectrum of research areas, contributing valuable insights to the ongoing discourse in bioactive materials and their applications. The journal's superior Scopus rankings further illustrate its influence, boasting impressive standings in engaging niches such as engineering and molecular biology. Bioactive Materials offers a vital platform for researchers, professionals, and students to disseminate and acquire cutting-edge knowledge, thus fostering innovation and collaboration in the rapidly evolving terrain of biomedicine. Its commitment to Open Access since 2016 enhances accessibility, ensuring that the burgeoning advancements in this field reach a global audience.
Biomaterials Advances
Elevating Biomaterials Science for a Healthier TomorrowBiomaterials Advances is a premier journal published by Elsevier, dedicated to the rapidly evolving field of biomaterials. Established in the United Kingdom, this open-access journal aims to disseminate high-quality, peer-reviewed research that explores innovative biomaterial designs and their applications in bioengineering and biomedical engineering. With an impressive 2023 impact factor reflected in its Q1 rankings across multiple categories—including Bioengineering, Biomaterials, and Biomedical Engineering—Biomaterials Advances stands out as a critical platform for scholars and practitioners faced with advancing technologies and methodologies in the realm of materials science. Covering a broad range of topics, from biocompatibility to tissue engineering, this journal provides an inclusive forum for researchers seeking to contribute to the field. Its Scopus rankings further affirm its position as a leading resource, with notable standings in Biomedical Engineering (Rank #13), Biomaterials (Rank #8), and Bioengineering (Rank #11), all within the top percentiles. Researchers and students alike are encouraged to contribute and engage with the latest findings and innovations in biomaterials through this valuable publication.
Journal of Biological Engineering
Elevating Interdisciplinary Collaboration in Biological SciencesJournal of Biological Engineering, published by BMC, stands as a prominent Open Access journal since 2007, dedicated to advancing the interdisciplinary field of biological engineering. With an ISSN of 1754-1611, this UK-based journal aims to provide a platform for researchers and professionals to disseminate innovative and impactful research across various domains including Biomedical Engineering, Environmental Engineering, Cell Biology, and Molecular Biology. The journal's notable rankings in the 2023 category quartiles exemplify its position within the scientific community, featuring Q2 status in Biomedical Engineering and Environmental Engineering, along with Q3 in Cell Biology and Q2 in Molecular Biology. By maintaining robust Scopus rankings and ensuring free access to cutting-edge research, the Journal of Biological Engineering plays a crucial role in driving discovery and collaboration among scholars, thereby enriching both the academic landscape and applied sciences.